Safety and utility of indwelling pleural catheters in lung transplant recipients

Abstract

AbstractIntroductionThe safety and efficacy of indwelling pleural catheters (IPCs) in lung allograft recipients is under‐reported.MethodsWe performed a multicenter, retrospective analysis between 1/1/2010 and 6/1/2022 of consecutive IPCs placed in lung transplant recipients. Outcomes included incidence of infectious and non‐infectious complications and rate of auto‐pleurodesis.ResultsSeventy‐one IPCs placed in 61 lung transplant patients at eight centers were included. The most common indication for IPC placement was recurrent post‐operative effusion. IPCs were placed at a median of 59 days (IQR 40–203) post‐transplant and remained for 43 days (IQR 25‐88). There was a total of eight (11%) complications. Infection occurred in five patients (7%); four had empyema and one had a catheter tract infection. IPCs did not cause death or critical illness in our cohort. Auto‐pleurodesis leading to the removal of the IPC occurred in 63 (89%) instances. None of the patients in this cohort required subsequent surgical decortication.ConclusionsThe use of IPCs in lung transplant patients was associated with an infectious complication rate comparable to other populations previously studied. A high rate of auto‐pleurodesis was observed. This work suggests that IPCs may be considered for the management of recurrent pleural effusions in lung allograft recipients.